Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Cancer statistics in China, 2015

Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text

Medicine, Oncology, Population Health Sciences +17

Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Yuichiro Ohe, Johan Vansteenkiste et al. · New England Journal of Medicine · 2017 · 5.3K citations · Full text

Medicine, Oncology, Pharmacology +16

Crystal structure of the tyrosine kinase domain of the human insulin receptor

Stevan R. Hubbard, Lei Wei, Wayne A. Hendrickson · Nature · 1994 · 1.1K citations

Life Sciences, Biochemistry, Molecular Biology +16

c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function

Jacqueline S. Biscardi, Ming‐Chei Maa, David A. Tice et al. · Journal of Biological Chemistry · 1999 · 645 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13